← Page 643

New Zealand Gazette – 1995 – No. 20

Page 644

Page 645 →

✨ Medicines Classification

644 NEW ZEALAND GAZETTE No. 20

Pilocarpine; and its salts

Pinacidil

Pipecuronium bromide

Podophyllotoxin; except when specified elsewhere

Podophyllum extracts; tinctures of podophyllum; podophyllin; in medicines containing more than 20% of podophyllum

Pravastatin; and its salts

Prilocaine; for parenteral use except when used by a dental therapist

Procaine; for parenteral use; for internal use

Propafenone hydrochloride

Propyliodone

Proxymetacaine; and its salts; except when used in practice by a registered optometrist

Radiographic contrast media; unless specified elsewhere in this notice

Quinapril

Quinine; and its salts; in medicines containing more than 50 mg per recommended daily dose

Ramipril

Recombinant human DNase

Remoxipride

Ribavirin

Rifabutin

Risperidone

Rocuronium bromide

Roxithromycin

Rubella vaccine

Salmeterol

Sermorelin

Sertraline hydrochloride

Simvastatin

Sodium diotiocarb

Sodium iodate

Solanaceous alkaloids; and their salts; in medicines containing more than 0.15% of solanaceous alkaloids calculated as hyoscyamine

Somatropin

Spirapril

Steroid hormones; either natural or synthetic, which exhibit anabolic activity

Stramonium; alkaloids of; and their salts; in medicines containing 0.15% or more of alkaloids calculated as hyoscyamine

Sultamicillin; and its salts

Sumatriptan; and its salts

Tazobactam

T cell receptor antibody

Teicoplanin

Terazosin; and its salts

Terbinafine; except for external use

Thymoxamine

Tibolone

Ticlopidine; and its salts

Tolrestat

Torasemide

Trandolapril

Trazodone

Tretinoin

Triptorelin

Tropicamide; except when used in practice by a registered optometrist

Tropisetron

Venlafaxine

Vigabatrin

Xamoterol

Zalcitabine

Zinc; and its salts; in medicines for internal use containing more than 25 mg of elemental zinc per recommended daily dose

Zuclopenthixol; and its salts and esters

Second Schedule

Restricted Medicines

Aciclovir; in medicines for external use; except in medicines for ophthalmological use

Alcohol, absolute; in medicines for internal and external use, except when compounded in a medicine

Aminacrine; and its salts; in medicines for external use

Amphotericin; for buccal use

Aspirin; in slow-release forms; in enteric-coated forms containing more than 300 mg per dose form

Bismuth; and its salts; in medicines for internal use

Beta 2-adrenoceptor agonists; except in medicines for inhalation or for parenteral use

Carbuterol; and its salts; except when contained in medicines for inhalation or for parenteral use

Ciclopirox; for dermatological use in medicines containing more than 1% of ciclopirox

Cimetidine; in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing not more than 14 days’ supply

Clindamycin; and its salts; in medicines for dermatological use

Clotrimazole; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Cholestyramine resin

Cromoglycate sodium; for nasal and ophthalmological use

Diclofenac; and its salts; in tablets or capsules containing 25 mg or less and in pack sizes of not more than 30 tablets or capsules

Dithranol; and its esters

Econazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Ether; except when used as a vehicle for a topical dose form

Ethyl chloride

Famotidine; in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing not more than 14 days’ supply

Fenoterol; and its salts; except in medicines for inhalation or for parenteral use

Glycopyrronium; and its salts; except in medicines for parenteral use

Hexoprenaline; and its salts; except in medicines for inhalation or for parenteral use

Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 1% or less and more than 0.5% by weight of hydrocortisone base with no other therapeutically active ingredient

PDF embedding disabled (Crown copyright)

View this page online at:

VUW Te Waharoa — NZ Gazette 1995, No 20

NZLII — NZ Gazette 1995, No 20

The General Assembly Library (on the right) was completed in 1899 and survived the 1907 fire. Now the oldest remaining original Parliament building, still used as the Parliamentary Library.

✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

Domain🏥 Health & Social Welfare
KeywordsMedicines, Prescription, Classification, Pharmacological Agents

As the Gazette has been published for more than 185 years, copyright status depends on the publication date of each issue:

1840–1925 (Public Domain): Issues of the New Zealand Gazette and Provincial Gazettes from this period are in the public domain, as the term of Crown copyright (100 years) has expired. Mechanical reproductions (e.g., scanned PDFs) of these public domain documents do not attract new copyright.
1926–1999 (Crown Copyright): Issues from this period remain subject to Crown copyright. Usage of these issues in this project is "Fair Dealing" for research purposes and consistent with the spirit of the open-access principles championed by NZGOAL, ie, "The default licensing position under ... NZGOAL is the Creative Commons Attribution 4.0 International licence ... [t]o the greatest extent possible, agencies should apply this licence to copyright material on their websites"
2000–Present (CC-BY 3.0 NZ): Gazette issues published on gazette.govt.nz are Crown copyright but are explicitly licensed by the Department of Internal Affairs under the Creative Commons Attribution 3.0 New Zealand licence (CC-BY 3.0 NZ). This project redistributes this content in accordance with those terms.

Nothing in this project is intended to infringe copyright, trademark law or personal privacy. Please contact me immediately if you have any concerns.

Third-Party Content

Where third-party content (e.g., notices submitted by external organisations) is identified within the Gazette, users should satisfy themselves regarding the copyright status of that specific content, as it may be subject to different ownership terms than the Gazette itself.

Sources and Attribution

NZ Gazette Sources

The primary sources for the issues of the NZ Gazette indexed by this project are:

New Zealand Gazette Archive, provided by Victoria University Library, copyright 2008 LexisNexis NZ Limited, Crown Copyright of New Zealand Gazette Office
- Issues from 1841-2008, including the New Munster, New Ulster, and Provincial Gazettes
New Zealand Gazettes by New Zealand Legal Information Institute (note: "NZLII is not the copyright owner in the source documents published on NZLII")
- Issues from 1913-1999
Gazette.govt.nz, Crown copyright / licensed by the Department of Internal Affairs under CC-BY 3.0 NZ
- Issues from 2000-2017

Additional Sources

Wellington City Recollect have made available a comprehensive and excellent-quality scan of the Wellington Provincial Gazette which was used to fill in a number of issues missing from Victoria University's Gazette Archive; in particular, all 1856 issues, issues 22-34 for 1864 and issues 9-19 for 1870.
27 issues of The New Zealand Advertiser and Bay of Islands Gazette (1840) were sourced from Papers Past (public domain).
Gazette Extraordinary No. 1 (1840), held at the Alexander Turnbull Library, Wellington, New Zealand. Imaged by Luke Howison at the National Library reading rooms; PDF released into the public domain.

PDF Icon

The PDF PDF Icon was made by Good Ware, CC BY-SA 4.0.

Masthead

The logo in the header is an edited version of “Winning Coat of Arms Competition Entry, 1908” by Archives New Zealand, CC BY 2.0 (found via Wikipedia).

Who made this?

I'm Luke Howison, a freelance web developer with an interest in genealogy. I have created several websites for genealogical research, such as NZ Ancestor Search Helper.